@jeffmarc after further thought I have decided to forego orgovyx: although Gleason is (4+3) 7, it is one core from the roi ( region of interest). 2 cores were 6 and the remaining were negative. Although the Decipher is .68 it is the lower end of the high risk and there were no cribiform clusters on pathology. I had a PSA 4 days ago of 2.4 and previous was 2.2. So to take the hormone blocker in order to increase survivability ( decrease biochemical recurrence) by 5-10% does not seem beneficial. It comes down to if this is a localized lesion that will be cured by SRBT or possibility of micro metastasis that will recur down the road. The side effects are not worth the 5-10% benefit of ADT.